Jeremy A Duke

Jeremy A Duke

Sanofi US - New Jersey / United States
Others
AD Scientific Index ID: 5440110
-
person_outline Jeremy A Duke's MOST POPULAR ARTICLES
1-) Enzymatic hydrolysis of pneumococcal capsular polysaccharide renders the bacterium vulnerable to host defenseDR Middleton, AV Paschall, JA Duke, FY AvciInfection and immunity 86 (8), 10.1128/iai. 00316-18, 2018232018
2-) Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell helpL Sun, AV Paschall, DR Middleton, M Ishihara, A Ozdilek, PL Wantuch, ...Nature Communications 11 (1), 2550, 2020202020
3-) Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate VaccineJA Duke, AV Paschall, LS Robinson, CJ Knoot, E Vinogradov, NE Scott, ...ACS infectious diseases 7 (11), 3111-3123, 2021152021
4-) Emerging vaccine strategies against the incessant pneumococcal diseaseJA Duke, FY Avcinpj Vaccines 8 (1), 122, 2023162023
5-) Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine designJA Duke, AV Paschall, J Glushka, A Lees, KW Moremen, FY AvciJournal of Biological Chemistry 298 (1), 2022162022